Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Thomas Anchordoquy to Animals

This is a "connection" page, showing publications Thomas Anchordoquy has written about Animals.

 
Connection Strength
  
 
 
0.721
  
  1. Tilden SG, Ricco MH, Hemann EA, Anchordoquy TJ. Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy. Eur J Pharm Sci. 2025 Jan 01; 204:106974.
    View in: PubMed
    Score: 0.050
  2. Betker JL, Anchordoquy TJ. The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-Bearing Mice. J Pharm Sci. 2022 07; 111(7):1926-1936.
    View in: PubMed
    Score: 0.040
  3. Fete MG, Betker JL, Shoemaker RK, Anchordoquy TJ. A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol. Ther Deliv. 2019 01; 10(1):11-20.
    View in: PubMed
    Score: 0.033
  4. Betker JL, Angle BM, Graner MW, Anchordoquy TJ. The Potential of Exosomes From Cow Milk for Oral Delivery. J Pharm Sci. 2019 04; 108(4):1496-1505.
    View in: PubMed
    Score: 0.033
  5. Betker JL, Jones D, Childs CR, Helm KM, Terrell K, Nagel MA, Anchordoquy TJ. Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery. J Control Release. 2018 09 28; 286:85-93.
    View in: PubMed
    Score: 0.032
  6. Betker JL, Anchordoquy TJ. Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery. Drug Deliv Transl Res. 2017 02; 7(1):162-167.
    View in: PubMed
    Score: 0.029
  7. Anchordoquy TJ, Barenholz Y, Boraschi D, Chorny M, Decuzzi P, Dobrovolskaia MA, Farhangrazi ZS, Farrell D, Gabizon A, Ghandehari H, Godin B, La-Beck NM, Ljubimova J, Moghimi SM, Pagliaro L, Park JH, Peer D, Ruoslahti E, Serkova NJ, Simberg D. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. ACS Nano. 2017 01 24; 11(1):12-18.
    View in: PubMed
    Score: 0.029
  8. Betker JL, Anchordoquy TJ. Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice. J Pharm Sci. 2017 03; 106(3):872-881.
    View in: PubMed
    Score: 0.028
  9. Betker JL, Anchordoquy TJ. Effect of charge ratio on lipoplex-mediated gene delivery and liver toxicity. Ther Deliv. 2015; 6(11):1243-53.
    View in: PubMed
    Score: 0.027
  10. Kullberg M, Martinson H, Mann K, Anchordoquy TJ. Complement C3 mediated targeting of liposomes to granulocytic myeloid derived suppressor cells. Nanomedicine. 2015 Aug; 11(6):1355-63.
    View in: PubMed
    Score: 0.025
  11. Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015 Feb 10; 199:145-55.
    View in: PubMed
    Score: 0.025
  12. Smyth T, Petrova K, Payton NM, Persaud I, Redzic JS, Graner MW, Smith-Jones P, Anchordoquy TJ. Surface functionalization of exosomes using click chemistry. Bioconjug Chem. 2014 Oct 15; 25(10):1777-84.
    View in: PubMed
    Score: 0.025
  13. Kullberg M, McCarthy R, Anchordoquy TJ. Systemic tumor-specific gene delivery. J Control Release. 2013 Dec 28; 172(3):730-6.
    View in: PubMed
    Score: 0.023
  14. Betker JL, Gomez J, Anchordoquy TJ. The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency. J Control Release. 2013 Nov 10; 171(3):261-8.
    View in: PubMed
    Score: 0.023
  15. Xu L, Betker J, Yin H, Anchordoquy TJ. Ligands located within a cholesterol domain enhance gene delivery to the target tissue. J Control Release. 2012 May 30; 160(1):57-63.
    View in: PubMed
    Score: 0.021
  16. Xu L, Wempe MF, Anchordoquy TJ. The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Ther Deliv. 2011 Apr; 2(4):451-60.
    View in: PubMed
    Score: 0.019
  17. Xu L, Anchordoquy T. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci. 2011 Jan; 100(1):38-52.
    View in: PubMed
    Score: 0.019
  18. Yu J, Anchordoquy TJ. Synergistic effects of surfactants and sugars on lipoplex stability during freeze-drying and rehydration. J Pharm Sci. 2009 Sep; 98(9):3319-28.
    View in: PubMed
    Score: 0.017
  19. Yu J, Anchordoquy TJ. Effects of moisture content on the storage stability of dried lipoplex formulations. J Pharm Sci. 2009 Sep; 98(9):3278-89.
    View in: PubMed
    Score: 0.017
  20. Molina MD, Anchordoquy TJ. Formulation strategies to minimize oxidative damage in lyophilized lipid/DNA complexes during storage. J Pharm Sci. 2008 Dec; 97(12):5089-105.
    View in: PubMed
    Score: 0.016
  21. Zhang Y, Bradshaw-Pierce EL, Delille A, Gustafson DL, Anchordoquy TJ. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci. 2008 Jan; 97(1):237-50.
    View in: PubMed
    Score: 0.015
  22. Molina Md, Anchordoquy TJ. Metal contaminants promote degradation of lipid/DNA complexes during lyophilization. Biochim Biophys Acta. 2007 Mar; 1768(3):669-77.
    View in: PubMed
    Score: 0.014
  23. Anchordoquy TJ, Armstrong TK, Molina Md. Low molecular weight dextrans stabilize nonviral vectors during lyophilization at low osmolalities: concentrating suspensions by rehydration to reduced volumes. J Pharm Sci. 2005 Jun; 94(6):1226-36.
    View in: PubMed
    Score: 0.013
  24. Armstrong TK, Anchordoquy TJ. Immobilization of nonviral vectors during the freezing step of lyophilization. J Pharm Sci. 2004 Nov; 93(11):2698-709.
    View in: PubMed
    Score: 0.012
  25. Molina Md, Armstrong TK, Zhang Y, Patel MM, Lentz YK, Anchordoquy TJ. The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci. 2004 Sep; 93(9):2259-73.
    View in: PubMed
    Score: 0.012
  26. Zhang Y, Anchordoquy TJ. The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim Biophys Acta. 2004 May 27; 1663(1-2):143-57.
    View in: PubMed
    Score: 0.012
  27. Armstrong TK, Girouard LG, Anchordoquy TJ. Effects of PEGylation on the preservation of cationic lipid/DNA complexes during freeze-thawing and lyophilization. J Pharm Sci. 2002 Dec; 91(12):2549-58.
    View in: PubMed
    Score: 0.011
  28. Lengsfeld CS, Anchordoquy TJ. Shear-induced degradation of plasmid DNA. J Pharm Sci. 2002 Jul; 91(7):1581-9.
    View in: PubMed
    Score: 0.010
  29. Molina MC, Allison SD, Anchordoquy TJ. Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators. J Pharm Sci. 2001 Oct; 90(10):1445-55.
    View in: PubMed
    Score: 0.010
  30. Fogueri U, Charkoftaki G, Roda G, Tuey S, Ibrahim M, Persaud I, Wempe MF, Brown JM, Thurman JM, Anchordoquy TJ, Joy MS. An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis. Drug Deliv Transl Res. 2022 06; 12(6):1445-1454.
    View in: PubMed
    Score: 0.010
  31. Anchordoquy TJ, Izutsu KI, Randolph TW, Carpenter JF. Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying. Arch Biochem Biophys. 2001 Jun 01; 390(1):35-41.
    View in: PubMed
    Score: 0.010
  32. Allison SD, Anchordoquy TJ. Mechanisms of protection of cationic lipid-DNA complexes during lyophilization. J Pharm Sci. 2000 May; 89(5):682-91.
    View in: PubMed
    Score: 0.009
  33. Anchordoquy TJ, Koe GS. Physical stability of nonviral plasmid-based therapeutics. J Pharm Sci. 2000 Mar; 89(3):289-96.
    View in: PubMed
    Score: 0.009
  34. Anchordoquy TJ, Girouard LG, Carpenter JF, Kroll DJ. Stability of lipid/DNA complexes during agitation and freeze-thawing. J Pharm Sci. 1998 Sep; 87(9):1046-51.
    View in: PubMed
    Score: 0.008
  35. Anchordoquy TJ, Carpenter JF, Kroll DJ. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. Arch Biochem Biophys. 1997 Dec 01; 348(1):199-206.
    View in: PubMed
    Score: 0.008
  36. Anchordoquy TJ, Carpenter JF. Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch Biochem Biophys. 1996 Aug 15; 332(2):231-8.
    View in: PubMed
    Score: 0.007
  37. Pozzi D, Caracciolo G, Capriotti AL, Cavaliere C, La Barbera G, Anchordoquy TJ, Lagan? A. Surface chemistry and serum type both determine the nanoparticle-protein corona. J Proteomics. 2015 Apr 24; 119:209-17.
    View in: PubMed
    Score: 0.006
  38. Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discov Today. 2014 Dec; 19(12):1945-52.
    View in: PubMed
    Score: 0.006
  39. Zillies JC, Zwiorek K, Hoffmann F, Vollmar A, Anchordoquy TJ, Winter G, Coester C. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles. Eur J Pharm Biopharm. 2008 Oct; 70(2):514-21.
    View in: PubMed
    Score: 0.004
  40. Abrams DJ, Zheng L, Choo KS, Yang JJ, Wei W, Anchordoquy TJ, Zawia NH, Stevens KE. An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients. Schizophr Res. 2008 Mar; 100(1-3):86-96.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)